- Home
- Equipment
- north america
- patients undergoing chemotherapy
Show results for
Refine by
Patients Undergoing Chemotherapy Equipment Supplied In North America
8 equipment items found
by:Enveric Biosciences, Inc. based inNaples, FLORIDA (USA)
Enveric Biosciences seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies. Preclinical data suggests combination therapies may improve the activity of certain chemotherapies or cancer immunotherapies, potentially enabling more potent or longer-lasting therapeutic effects. In addition, combination therapies may allow for the same or greater therapeutic effect ...
Manufactured by:Gentuity, LLC based inSudbury, MASSACHUSETTS (USA)
SIR-Spheres Y-90 resin microspheres are a specialized medical product designed to treat specific types of liver cancer. The product employs yttrium-90, a radioactive isotope that emits beta radiation, which is delivered directly to liver tumors via resin microspheres. This form of localized, targeted radiation therapy allows for high-dose treatment while minimizing exposure to surrounding healthy ...
Manufactured by:Alphageneron based inCambridge, MASSACHUSETTS (USA)
An autologous mHsp70 targeted NK Cell Therapy that activates NK cells to target and kill cells expressing mHsp70. The therapy begins with selecting patients whom have high mHsp70 expression with our Companion Diagnostic AP-CDx (described below), collecting their peripheral blood mononuclear cells (PBMCs) by leukapheresis, ex vivo activation of PBMCs with our synthetic Hsp70-derived peptide ...
Manufactured by:Neo Medical, Inc. based inSparks, NEVADA (USA)
2.5 Fr x 50cm, SL Polyurethane PICC with E-Z Flush Stylet, 4cm Tearaway Introducer & .010 x 20cm nitinol ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Sacituzumab is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 (TROP2). Sacituzumab demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab is used for the synthesis of antibody-drug conjugates (ADC) drugs. Antibody-drug conjugates with ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Tegafur (FT 207; NSC 148958) is a chemotherapeutic 5-FU proagent used in the treatment of cancers; is a component of ...
Manufactured by:Neuropathix, Inc. based inDoylestown, PENNSYLVANIA (USA)
Neuropathix has focused its science on the research and development of a pipeline of next generation socially responsible pain management ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC ...